Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression - Wikidata - awgldk - TriplyDB

Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

http://www.wikidata.org/entity/Q27477482

about

Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions Innate immune responses in hepatitis C virus infection Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy Negative regulation of cytoplasmic RNA-mediated antiviral signaling Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1 Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A.Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.Interferon-λ in HCV Infection and Therapy.Chemokines in the immunopathogenesis of hepatitis C infection Hepatitis C virus, human immunodeficiency virus and Pseudomonas phage PS5 triad share epitopes of immunogenic determinants Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression.Hepatitis C virus virology and new treatment targets.Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.Increased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.Toll-like receptors and liver disease.The role of chemokines in hepatitis C virus-mediated liver disease Progress in the development of vaccines for hepatitis C virus infection.Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females.Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation post-entry.Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C.Hepatitis C virus NS3/4A protease blocks IL-28 production.Toll-like receptors and innate immune responses in systemic lupus erythematosus.Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C.

P2860

Q24301741-45CE8304-AEE9-41C6-B01A-A49BA1247B8B Q27023055-C9A9CF15-5667-4138-8433-B7D440E663B7 Q27485023-2563CD6C-F70C-4BF6-8740-46A2A07A06CB Q27486013-F3F94C03-8A3E-418D-A17E-242E2120FE94 Q27487296-29269795-67CD-4720-93AC-51B64353B368 Q27488889-4EFCEA0D-3228-410F-A3EF-2A876B961A73 Q30389518-613DD3B4-F064-47B5-98F7-6F0B85A7F176 Q33641410-DDEF07DC-C815-4450-AA37-393A8D05BC46 Q33716908-2736D3C9-1AD4-4E29-AFA0-0A25A846D0E8 Q33808107-1ABF6FE4-3E8C-4EBE-B3A4-A249E2ED0761 Q33939184-8337EF95-536E-416B-80CF-3555CA5B0671 Q34047500-1252BA58-4805-47FB-B3A3-D9C661FEB57C Q34056271-262A0950-AA64-456F-BF5B-8E600A8EE121 Q34426709-4E575227-66E0-4EAB-A43C-5E47915C81A2 Q34583718-6774EBB2-DDCB-4685-9C6F-42377C5FF8B2 Q34974042-25822FC1-5D9D-4370-B152-0983438B01CF Q35560734-7892275D-B80F-430B-BCBE-F0F1C664DD32 Q36996953-2289E400-008F-4352-903C-C0EDA6CA75FE Q37774371-A4F393DA-DF7E-4AC8-951B-1298AA0E6909 Q38151944-B02EEFD5-79A0-48DD-87CA-021C6026C325 Q38197441-9892A75D-39F0-4D60-8FEC-D56AC6544BA8 Q38635596-80F07F1B-B226-4C98-975F-7874F26BF4CF Q39000991-977AC708-5145-43CE-9154-A7526920A352 Q40548291-0FBC3172-55A8-4804-A8F7-C1B5FDD60ED7 Q41928238-7C3A1EE1-66FC-46FA-B0FD-BF582C2E7389 Q42978470-3BAFB4A8-86F0-4628-8D28-28439F8BD5D5 Q42981120-12B1ED92-579A-4F72-897E-8165FF5BF49F Q43049852-3AF46428-4745-4870-B9A7-B9C4AC421062 Q44246682-42FCAF5D-93D2-4D5E-8741-0AA7469A2254

P2860

Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

http://www.wikidata.org/entity/Q27477482

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@ast

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@en

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@nl

type

label

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@ast

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@en

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@nl

prefLabel

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@ast

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@en

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@nl

P1433

Q27477482-6BD6691A-ACCE-4353-9C4D-2477BCD4073E

P1476

Q27477482-BC51058C-F4F2-43CA-A4FB-532EEFC06488

P2093

Q27477482-3EDA4AF2-D0F6-491B-89CE-762A96065C40

Q27477482-49B153BD-6223-47C4-909D-FD6B78B90CD7

Q27477482-58EBE682-D32B-483F-A840-C1EE761CE036

Q27477482-6D6B8C71-B313-4A3B-8079-F220D88B6A39

Q27477482-74AB1002-B817-4935-914E-EFB497D63567

Q27477482-8D598018-2CF5-4036-A054-2DF16B697C2D

P2860

Q27477482-048A5E99-7169-444A-824C-87A015E290FD

Q27477482-17489773-FDA4-46E0-96E9-0517FD95DBC9

Q27477482-1848110B-6BF5-46A5-B3EB-7D125FF9800E

Q27477482-1CBD00D7-FC31-4CC0-827B-07469348CAD3

Q27477482-2771E6F9-C447-4850-B32F-1CFBF9011F00

Q27477482-38308756-6FC5-49C3-9A1B-EFA19D9B9960

Q27477482-457DF10C-3753-4941-B74C-3DD80DA61CA8

Q27477482-4C6F5A69-868D-4051-82CF-00D60E1045CB

Q27477482-4F17C522-48A1-4FF0-8511-74CF42407343

Q27477482-4F1F2D29-5628-4D14-B0D9-36BD26A6B99D

P2888

Q27477482-FE76A441-051D-4138-AABF-C0FF66122450

P304

Q27477482-3FC7E25E-C81F-4BFD-BF8C-602C8A956CD1

P31

Q27477482-5EE63DDE-0F42-448A-8FCE-60A4FA912674

P356

Q27477482-3036180B-2F7F-44F2-85E8-6679460512DE

P433

Q27477482-711A3528-576E-45FB-972A-5763F2EA1350

P478

Q27477482-B0E5C887-913B-4AA5-B6E5-301BB19933A1

P50

Q27477482-B48DE0DD-1A35-49E3-9734-BC98D0066BB2

P577

Q27477482-64264711-8DE0-4BBF-B4D2-50E5900B8185

P6179

Q27477482-AEE31984-64B5-4C2A-B119-98B922A0DFB0

P698

Q27477482-1BEE3D18-B314-4846-8C90-C6E3A18EA1A4

P921

Q27477482-E2F68716-CE66-44A3-83E6-9AA8C1528260

P932

Q27477482-8262D1D6-976C-4EFE-87EE-A48FC513617B

P356

P1433

Virology Journal

P1476

Hepatitis C virus NS2 and NS3/ ...... kine/chemokine gene expression

@en

P2093

Ilkka Julkunen

http://www.w3.org/2001/XMLSchema#string

Krister Melén

http://www.w3.org/2001/XMLSchema#string

Maarit Sillanpää

http://www.w3.org/2001/XMLSchema#string

Pasi Kaukinen

http://www.w3.org/2001/XMLSchema#string

Rongtuan Lin

http://www.w3.org/2001/XMLSchema#string

Sergei Kotenko

http://www.w3.org/2001/XMLSchema#string

P2860

The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation

Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

P2888

P304

66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1743-422X-3-66

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031702285

http://www.w3.org/2001/XMLSchema#string

P698

16945160

http://www.w3.org/2001/XMLSchema#string

P921

P932

1569370

http://www.w3.org/2001/XMLSchema#string